Matias Serebrinsky
substackInactive

PsyMed Ventures Newsletter

by Matias Serebrinsky·Last posted 5 months ago

About Matias Serebrinsky

Analyzes psychedelic medicine, biopharma, and venture capital. Provides key insights into the startups and trends shaping health innovation.